DexCom Inc (DXCM) - Financial and Strategic SWOT Analysis Review
November 2019
48
About the Report
About the Report
DexCom Inc (DXCM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Dexcom Inc (Dexcom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring (CGM) systems. The company's major products include integrated CGM systems for adults and pediatric use, insulin pumps, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products in the North America, Asia, Latin America and the Middle East through direct sales force and a network of distributors. Dexcom is headquartered in San Diego, California, the US.
DexCom Inc Key Recent Developments
Sep 17,2019: Dexcom appoints Bridgette Heller to Board of Directors
Sep 17,2019: Dexcom promotes Quentin Blackford to Chief Operating Officer
Aug 23,2019: Court rules that the patents asserted against Dexcom CGM systems are invalid
Jul 31,2019: Dexcom reports second quarter 2019 financial results
May 01,2019: Dexcom reports first quarter 2019 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
DexCom Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Abbott Diabetes Care Inc
Becton Dickinson and Co
Ascensia Diabetes Care US Inc
Medtronic Diabetes
LifeScan Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
DexCom Inc-Key Facts
DexCom Inc-Key Employees
DexCom Inc-Key Employee Biographies
DexCom Inc-Major Products and Services
DexCom Inc-History
DexCom Inc-Company Statement
DexCom Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
DexCom Inc-Business Description
Geographical Segment: Outside of the US
Performance
Geographical Segment: The US
Performance
R&D Overview
DexCom Inc-Corporate Strategy
DexCom Inc-SWOT Analysis
SWOT Analysis-Overview
DexCom Inc-Strengths
DexCom Inc-Weaknesses
DexCom Inc-Opportunities
DexCom Inc-Threats
DexCom Inc-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
DexCom Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
DexCom Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
DexCom Inc, Recent Deals Summary
Section 5-Company's Recent Developments
Sep 17, 2019: Dexcom appoints Bridgette Heller to Board of Directors
Sep 17, 2019: Dexcom promotes Quentin Blackford to Chief Operating Officer
Aug 23, 2019: Court rules that the patents asserted against Dexcom CGM systems are invalid
Jul 31, 2019: Dexcom reports second quarter 2019 financial results
May 01, 2019: Dexcom reports first quarter 2019 financial results
Feb 27, 2019: A new integration: Fitabase and Dexcom
Feb 21, 2019: Dexcom reports fourth quarter and fiscal year 2018 financial results
Jan 07, 2019: Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2018 and Provides Initial 2019 Outlook
Dec 18, 2018: Dexcom announces upcoming conference presentation
Nov 06, 2018: DexCom announces third quarter 2018 financial results
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
DexCom Inc, Performance Chart (2014-2018)
DexCom Inc, Ratio Charts
DexCom Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
DexCom Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
DexCom Inc, Key Facts
DexCom Inc, Key Employees
DexCom Inc, Key Employee Biographies
DexCom Inc, Major Products and Services
DexCom Inc, History
DexCom Inc, Subsidiaries
DexCom Inc, Key Competitors
DexCom Inc, Ratios based on current share price
DexCom Inc, Annual Ratios
DexCom Inc, Annual Ratios (Cont...1)
DexCom Inc, Interim Ratios
DexCom Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
DexCom Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
DexCom Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.